Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume $0.53 +0.02 (+3.46%) As of 05/23/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Elite Pharmaceuticals Short Interest DataElite Pharmaceuticals (ELTP) has a short interest of 1.99 million shares. This marks a -0.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 944,006 shares to cover all short positions.Current Short Interest1,987,600 sharesPrevious Short Interest1,988,500 sharesChange Vs. Previous Month-0.05%Dollar Volume Sold Short$822,071.36Short Interest Ratio2.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,068,363,000 sharesPercentage of Shares Shorted0.19%Today's Trading Volume591,696 sharesAverage Trading Volume944,006 sharesToday's Volume Vs. Average63% Short Selling Elite Pharmaceuticals? Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELTP Short Interest Over TimeELTP Days to Cover Over TimeELTP Percentage of Float Shorted Over Time Elite Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20251,987,600 shares $822,071.36 -0.1%N/A2.2 $0.41 4/15/20251,988,500 shares $845,907.90 +1.0%0.2%0.7 $0.43 3/31/20251,968,400 shares $856,254.00 -0.8%0.2%1.6 $0.44 3/15/20251,984,000 shares $960,057.60 +0.1%0.2%1.7 $0.48 2/28/20251,982,000 shares $970,981.80 -5.8%0.2%1 $0.49 2/15/20252,105,000 shares $1.12 million +3.6%0.2%0.8 $0.53 1/31/20252,031,600 shares $1.02 million +3.0%N/A1.3 $0.50 1/15/20251,972,500 shares $946,800.00 -1.8%N/A0.6 $0.48 12/31/20242,008,300 shares $1.09 million -26.1%N/A0.8 $0.54 12/15/20242,717,700 shares $1.34 million +7.6%N/A0.9 $0.49 Get the Latest News and Ratings for ELTP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elite Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20242,526,500 shares $1.49 million +52.7%N/A0.5 $0.59 11/15/20241,654,500 shares $929,001.75 +6.0%N/A0.4 $0.56 10/31/20241,560,500 shares $692,549.90 -22.1%N/A0.1 $0.44 10/15/20242,004,100 shares $883,006.46 -1.6%N/A0.6 $0.44 9/30/20242,036,000 shares $789,968.00 -7.3%N/A0.6 $0.39 9/15/20242,195,500 shares $790,599.55 +19.7%N/A0.2 $0.36 8/31/20241,834,800 shares $507,597.42 +10.5%N/A0.3 $0.28 8/15/20241,661,100 shares $317,436.21 +5.0%N/A1 $0.19 7/31/20241,581,500 shares $294,159.00 -9.2%N/A1.4 $0.19 7/15/20241,740,800 shares $330,752.00 +7.1%N/A1 $0.19 6/30/20241,625,700 shares $323,514.30 +4.8%N/A1 $0.20 6/15/20241,550,800 shares $261,092.69 -2.4%N/A2.4 $0.17 5/31/20241,588,700 shares $274,845.10 +3.8%N/A1.3 $0.17 5/15/20241,530,700 shares $214,144.93 -4.1%N/A1.3 $0.14 4/30/20241,595,900 shares $207,147.82 -0.3%N/A1.8 $0.13 4/15/20241,601,300 shares $216,175.50 +2.9%N/A1.4 $0.14 3/31/20241,555,700 shares $240,106.74 -7.7%N/A1.4 $0.15 3/15/20241,684,700 shares $234,173.30 +5.1%N/A0.9 $0.14 2/29/20241,602,900 shares $258,066.90 +0.9%N/A0.4 $0.16 2/15/20241,588,800 shares $293,769.12 +75.2%N/A0.5 $0.18 1/15/2024103,200 shares $18,008.40 +24.8%N/A0 $0.17 12/31/202382,700 shares $11,578.00 No ChangeN/A0 $0.14 11/30/202380,600 shares $11,084.11 +58.4%N/A0 $0.14 11/15/202350,900 shares $7,380.50 No ChangeN/A0 $0.15 10/15/2023228,000 shares $21,831.00 +113.5%N/A0.3 $0.10 9/30/2023106,800 shares $10,019.44 +862.2%N/A0.1 $0.09 9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08 8/31/2023211,700 shares $18,629.60 +1,283.7%N/A0 $0.09 8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05 7/31/202360,300 shares $2,532.60 +102.4%N/A0 $0.04Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 7/15/202329,800 shares $1,132.40 No ChangeN/A0 $0.04 6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03 5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03 5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03 4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03 4/15/2023300 shares $9.30 -93.6%N/A0 $0.03 3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03 3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03 2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04 2/15/202344,200 shares $1,701.70 +44.9%N/A0.1 $0.04 1/31/202330,500 shares $1,030.90 +74.3%N/A0 $0.03 1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03 12/30/2022800 shares $23.60 +700.0%N/A0 $0.03 12/15/2022100 shares $3.00 -99.0%N/A0 $0.03 11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03 11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03 10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04 10/15/202242,800 shares $1,326.80 No ChangeN/A0 $0.03 9/15/2022400 shares $14.40 -99.4%N/A0 $0.04 8/31/202269,300 shares $2,477.48 -2.8%N/A0 $0.04 8/15/202271,300 shares $3,208.50 No ChangeN/A0.1 $0.05 7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04 6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05 5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05 4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04 2/28/2022212,900 shares $8,516.00 +3,030.9%N/A0.2 $0.04 2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04 1/31/202264,500 shares $2,547.75 No ChangeN/A0.1 $0.04 12/31/2021100 shares $3.31 No ChangeN/A0 $0.03 12/15/2021100 shares $3.70 -99.6%N/A0 $0.04 11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04 11/15/2021100 shares $3.82 -98.9%N/A0 $0.04 10/29/20219,400 shares $362.84 -38.2%N/A0 $0.04 10/15/202115,200 shares $608.00 +280.0%N/A0 $0.04 9/30/20214,000 shares $172.00 No ChangeN/A0 $0.04 8/31/202111,500 shares $543.95 +8.5%N/A0 $0.05 8/13/202110,600 shares $484.42 -46.7%N/A0 $0.05 7/30/202119,900 shares $953.21 +74.6%N/A0 $0.05 7/15/202111,400 shares $550.62 No ChangeN/A0 $0.05 6/15/202112,200 shares $668.56 No ChangeN/A0 $0.05 5/14/202121,600 shares $1,252.80 +151.2%N/A0 $0.06 4/30/20218,600 shares $467.41 No ChangeN/A0 $0.05 3/31/20211,500 shares $87.00 -89.2%N/A0 $0.06 3/15/202113,900 shares $847.90 -65.6%N/A0 $0.06 2/26/202140,400 shares $2,585.60 +1,054.3%N/A0 $0.06 2/12/20213,500 shares $261.80 +218.2%N/A0 $0.07 1/29/20211,100 shares $64.35 -83.3%N/A0 $0.06 12/31/202012,500 shares $675.00 No ChangeN/A0 $0.05 11/30/202027,400 shares $1,479.60 -68.4%N/A0 $0.05 11/15/202086,700 shares $6,675.90 No ChangeN/A0.1 $0.08Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 10/15/202012,100 shares $847.00 No ChangeN/A0 $0.07 8/31/202073,800 shares $5,830.20 +939.4%N/A0 $0.08 8/14/20207,100 shares $477.83 -92.6%N/A0 $0.07 7/31/202096,500 shares $6,031.25 +222.7%N/A0.1 $0.06 7/15/202029,900 shares $2,299.31 +121.5%N/A0 $0.08 6/30/202013,500 shares $1,120.50 -59.0%N/A0 $0.08 6/15/202032,900 shares $2,961.00 No ChangeN/A0 $0.09 ELTP Short Interest - Frequently Asked Questions What is Elite Pharmaceuticals' current short interest? Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,987,600 shares of ELTP short. Learn More on Elite Pharmaceuticals' current short interest. What is a good short interest ratio for Elite Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 2.0. Learn More on Elite Pharmaceuticals's short interest ratio. Is Elite Pharmaceuticals' short interest increasing or decreasing? Elite Pharmaceuticals saw a decline in short interest in April. As of April 30th, there was short interest totaling 1,987,600 shares, a decline of 0.0% from the previous total of 1,988,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Elite Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Elite Pharmaceuticals: Beam Therapeutics Inc. (19.15%), Recursion Pharmaceuticals, Inc. (30.25%), Apogee Therapeutics, Inc. (28.66%), Galapagos NV (2.93%), Tarsus Pharmaceuticals, Inc. (19.78%), Schrödinger, Inc. (13.62%), Bausch Health Companies Inc. (3.38%), Agios Pharmaceuticals, Inc. (7.05%), Centessa Pharmaceuticals plc (6.32%), Arcutis Biotherapeutics, Inc. (12.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Elite Pharmaceuticals stock? Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. ELTP shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elite Pharmaceuticals? A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further. How often is Elite Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Beam Therapeutics Short Interest Recursion Pharmaceuticals Short Interest Apogee Therapeutics Short Interest Galapagos Short Interest Tarsus Pharmaceuticals Short Interest Schrödinger Short Interest Bausch Health Companies Short Interest Agios Pharmaceuticals Short Interest Centessa Pharmaceuticals Short Interest Arcutis Biotherapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ELTP) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
